{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:28:09Z","timestamp":1790364489831,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.4158\/ep13093.ra","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T21:18:33Z","timestamp":1372799913000},"page":"1043-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature"],"prefix":"10.1016","volume":"19","author":[{"given":"Luca","family":"Tomisti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia Del","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bartalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Pambianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Pambianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis E.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enio","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Bogazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP13093.RA_bb0010","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0735-1097(03)00416-9","article-title":"American Heart Association\/American College of Cardiology Foundation guide to warfarin therapy","volume":"41","author":"Hirsh","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP13093.RA_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2217\/pgs.11.184","article-title":"Prediction of warfarin dose: why, when and how?","volume":"13","author":"Eriksson","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.4158\/EP13093.RA_bb0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/clpt.1992.39","article-title":"The mechanism of the interaction between amiodarone and warfarin in humans","volume":"51","author":"Heimark","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.4158\/EP13093.RA_bb0025","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"key":"10.4158\/EP13093.RA_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jc.2012-1797","article-title":"Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction","volume":"97","author":"Tomisti","year":"2012","journal-title":"Endocrinol Metab"},{"key":"10.4158\/EP13093.RA_bb0035","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","author":"Bogazzi","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13093.RA_bb0040","first-page":"340","article-title":"Amiodarone and the thyroid: a 2012 update","volume":"35","author":"Bogazzi","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP13093.RA_bb0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","article-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","volume":"360","author":"Klein","year":"2009","journal-title":"N Engl J Med"},{"key":"10.4158\/EP13093.RA_bb0050","first-page":"1692","article-title":"American Heart Association\/American College of Cardiology Foundation. American Heart Association\/American College of Cardiology Foundation guide to warfarin therapy","volume":"107","author":"Hirsh","year":"2003","journal-title":"Pharmacogenomics"},{"key":"10.4158\/EP13093.RA_bb0055","article-title":"Warfarin: genotyping and improving dosing","volume":"33","author":"Shindley","year":"2008","journal-title":"Communiqu\u00e9"},{"key":"10.4158\/EP13093.RA_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/GIM.0b013e318163c35f","article-title":"Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin","volume":"10","author":"Flockhart","year":"2008","journal-title":"Genet Med"},{"key":"10.4158\/EP13093.RA_bb0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/MBC.0b013e3282f09de2","article-title":"Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: a case report","volume":"18","author":"Squizzato","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.4158\/EP13093.RA_bb0070","first-page":"43","article-title":"Problems of anticoagulation with warfarin in hyperthyroidism","volume":"58","author":"Kellett","year":"1986","journal-title":"Q J Med"},{"key":"10.4158\/EP13093.RA_bb0075","first-page":"53","article-title":"Possible association of venous thromboembolism and hyperthyroidism: 4 case reports and literature review","volume":"121","author":"Kim","year":"2008","journal-title":"N Z Med J"},{"key":"10.4158\/EP13093.RA_bb0080","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1210\/jc.2007-0199","article-title":"Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review","volume":"92","author":"Squizzato","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13093.RA_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.md.0000123095.65294.34","article-title":"Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland","volume":"83","author":"Kurnik","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP13093.RA_bb0090","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.1975.03240230039019","article-title":"Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism","volume":"231","author":"Self","year":"1975","journal-title":"JAMA"},{"key":"10.4158\/EP13093.RA_bb0095","first-page":"69","article-title":"Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis","volume":"131","author":"Vagenakis","year":"1972","journal-title":"Johns Hopkins Med J"},{"key":"10.4158\/EP13093.RA_bb0100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00007611-198505000-00024","article-title":"Apathetic thyrotoxicosis due to hemorrhage into a hyperfunctioning thyroid nodule after excessive anticoagulation","volume":"78","author":"Olchovsky","year":"1985","journal-title":"South Med J"},{"key":"10.4158\/EP13093.RA_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/eje.1.01857","article-title":"Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism","volume":"152","author":"Gullu","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP13093.RA_bb0110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/clpt.2012.171","article-title":"A population-based assessment of the drug interaction between levothyroxine and warfarin","volume":"92","author":"Pincus","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.4158\/EP13093.RA_bb0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/clpt.2011.283","article-title":"Warfarin-amiodarone drug-drug interactions: determination of [I](u)\/K(I,u) for amiodarone and its plasma metabolites","volume":"91","author":"McDonald","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.4158\/EP13093.RA_bb0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/0091270009351885","article-title":"An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone","volume":"50","author":"Edwin","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.4158\/EP13093.RA_bb0125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2146\/ajhp060415","article-title":"Characteristics of the amiodarone-warfarin interaction during long-term follow-up","volume":"65","author":"Lu","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.4158\/EP13093.RA_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.121.1.19","article-title":"Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland","volume":"121","author":"Sanoski","year":"2002","journal-title":"Chest"},{"key":"10.4158\/EP13093.RA_bb0135","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1001\/archinte.1988.00380080065018","article-title":"The incidence, magnitude, and time course of the amiodarone-warfarin interaction","volume":"148","author":"Kerin","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP13093.RA_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/107424840100600405","article-title":"Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy","volume":"6","author":"Naganuma","year":"2001","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.4158\/EP13093.RA_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00543320","article-title":"Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination","volume":"28","author":"Almog","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.4158\/EP13093.RA_bb0150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2125.1985.tb05135.x","article-title":"Amiodarone reduces plasma warfarin clearance in man","volume":"83","author":"Watt","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"10.4158\/EP13093.RA_bb0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1067\/mcp.2001.117444","article-title":"Interindividual variability in sensitivity to warfarin--Nature or nurture?","volume":"70","author":"Loebstein","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.4158\/EP13093.RA_bb0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1345\/aph.1Q217","article-title":"Elevated international normalized ratio associated with use of dronedarone and warfarin","volume":"45","author":"Pogge","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.4158\/EP13093.RA_bb0165","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ahj.2010.11.013","article-title":"An important indirect drug interaction between dronedarone and warfarin that may be extrapolated to other drugs that can alter gastrointestinal function","volume":"161","author":"Reiffel","year":"2011","journal-title":"Am Heart J"},{"key":"10.4158\/EP13093.RA_bb0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ahj.2010.07.008","article-title":"Dronedarone and vitamin K antagonists: a review of drug-drug interactions","volume":"160","author":"Shirolkar","year":"2010","journal-title":"Am Heart J"},{"key":"10.4158\/EP13093.RA_bb0175","first-page":"49","article-title":"Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis","volume":"170","author":"Woeber","year":"1999","journal-title":"West J Med"},{"key":"10.4158\/EP13093.RA_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00008571-200003000-00001","article-title":"CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates","volume":"10","author":"Takanashi","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.4158\/EP13093.RA_bb0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2004-06-2111","article-title":"A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin","volume":"105","author":"D\u2019Andrea","year":"2005","journal-title":"Blood"},{"key":"10.4158\/EP13093.RA_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00008571-199402000-00005","article-title":"Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9","volume":"4","author":"Rettie","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.4158\/EP13093.RA_bb0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00008571-199710000-00004","article-title":"Genetic association between sensitivity to warfarin and expression of CYP2C9*3","volume":"7","author":"Steward","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.4158\/EP13093.RA_bb0200","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1182\/blood-2007-01-069609","article-title":"Genetic-based dosing in orthopedic patients beginning warfarin therapy","volume":"110","author":"Millican","year":"2007","journal-title":"Blood"},{"key":"10.4158\/EP13093.RA_bb0205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(98)04474-2","article-title":"Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications","volume":"353","author":"Aithal","year":"1999","journal-title":"Lancet"},{"key":"10.4158\/EP13093.RA_bb0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature02254","article-title":"Identification of the gene for vitamin K epoxide reductase","volume":"427","author":"Li","year":"2004","journal-title":"Nature"},{"key":"10.4158\/EP13093.RA_bb0215","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0708078","article-title":"Genetic determinants of response to warfarin during initial anticoagulation","volume":"358","author":"Schwarz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4158\/EP13093.RA_bb0220","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.jacc.2010.03.009","article-title":"Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study)","volume":"55","author":"Epstein","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP13093.RA_bb0225","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jbspin.2006.12.006","article-title":"Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis","volume":"74","author":"Sellam","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.4158\/EP13093.RA_bb0230","first-page":"2354","article-title":"Effects of prednisone on the International Normalized Ratio","volume":"63","author":"Stading","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP13093.RA_bb0235","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF03349025","article-title":"Color flow Doppler sonography in thyrotoxicosis factitia","volume":"19","author":"Bogazzi","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP13093.RA_bb0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF03347021","article-title":"Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis","volume":"26","author":"Bogazzi","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP13093.RA_bb0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis","volume":"7","author":"Bogazzi","year":"1997","journal-title":"Thyroid"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20431246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20431246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/0880141736133G16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:56:32Z","timestamp":1761515792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20431246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1530891X20431246"],"URL":"https:\/\/doi.org\/10.4158\/ep13093.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP13093.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}